Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ EPS8L2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA529447
Description
Recommended positive controls: A431, HepG2. Predicted reactivity: Mouse (82%), Rat (82%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene has been shown to be involved in the regulation of cell proliferation, and in the crosstalk between the adiponectin signalling and insulin signalling pathways. The encoded protein binds many other proteins, including RAB5A, DCC, AKT2, PIK3CA, adiponectin receptors, and proteins of the NuRD/MeCP1 complex. This protein is found associated with endosomal membranes, but can be released by EGF and translocated to the nucleus.
Specifications
EPS8L2 | |
Polyclonal | |
Unconjugated | |
EPS8L2 | |
AI042819; AW545405; Epidermal growth factor receptor kinase substrate 8-like protein 2; epidermal growth factor receptor pathway substrate 8-like protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2; EPS8 like 2; EPS8 related protein 2; Eps8l2; EPS8-like 2; EPS8-like protein 2; EPS8R2; EPS8-related protein 2; PP13181 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
100856027, 64787 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q9H6S3 | |
EPS8L2 | |
Recombinant protein encompassing a sequence within the center region of human EPS8L2. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Canine, Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction